A Scandinavian study identifies major ketoacidosis risk factors among people with Type 2 diabetes receiving SGLT2 inhibitors.

In this episode, recorded at the American Society of Clinical Oncology (ASCO) Annual Meeting 2026, we speak to Pooja Advani, ...

Large Norwegian cohort finds no broad link between prenatal COVID-19 and neurodevelopmental disorders, but discover the one ...

NHS patients in England can now access Enhertu, a breast cancer drug shown to extend survival by almost seven months.

A RANDOMISED clinical trial has shown that Desmodium styracifolium total flavone capsules, known as Guang Jing Qian Cao, ...

HEPA air filtration was associated with faster cognitive test performance among adults aged 40 years and older. Read more.

An interpretable machine learning model predicted moderate to severe acute kidney injury risk in ICU patients with acute ...

MRI research links severe Type 2 asthma with differences in brain structure and white matter associated with inflammation ...

EMJ recently spoke to Derek Gilroy, Head of Department of Experimental & Translational Medicine, University College London, UK, about ...

Discover what makes clinicians embrace new drug launches and what holds them back, through the revealing HCP insights and ...

Novo Nordisk signs a deal worth up to $1.4bn with Orbis Medicines to develop oral drugs for cardiometabolic diseases.

Building the Lupus Center meant focusing on the three pillars essential to both patient care and research. Patients are the ...